BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/22/2026 6:58:05 AM | Browse: 5 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer: Current evidence, persistent uncertainties, and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ze-Wei Cheng, Yi-Ze Liang, Meng Wei, Zhi-Bo Yan, Guo-Rui Sun, Xiao-Han Cui and Wen-Bin Yu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Horizontal Project of Shandong University |
No. 6010123193, No. 6010121066, and No. 6010125120 |
|
| Corresponding Author |
Wen-Bin Yu, MD, PhD, Professor, Department of General Surgery, Qilu Hospital of Shandong University, No. 107 Wenhuaxi Road, Jinan 250012, Shandong Province, China. wenbin_yu2003@163.com |
| Key Words |
Gastric cancer; Prophylactic hyperthermic intraperitoneal chemotherapy; Peritoneal recurrence; Patient selection; Safety; Prognosis |
| Core Tip |
Prophylactic hyperthermic intraperitoneal chemotherapy aims to eliminate occult free cancer cells following curative gastrectomy for locally advanced gastric cancer, thereby reducing peritoneal recurrence. While meta-analyses suggest potential improvements in survival and peritoneal control, conflicting trial results and persistent protocol heterogeneity preclude definitive recommendations. Although prophylactic hyperthermic intraperitoneal chemotherapy appears generally safe, it carries distinct risks that demand vigilant monitoring, including renal impairment, pulmonary dysfunction, and hematologic toxicity. Optimal patient selection, guided by serosal invasion, nodal burden, diffuse histology, and positive peritoneal cytology, remains paramount. Ongoing trials and novel combinatorial strategies may help clarify its therapeutic role. |
| Citation |
Cheng ZW, Liang YZ, Wei M, Yan ZB, Sun GR, Cui XH, Yu WB. Prophylactic hyperthermic intraperitoneal chemotherapy for gastric cancer: Current evidence, persistent uncertainties, and future perspectives. World J Gastroenterol 2026; In press |
 |
Received |
|
2026-01-12 01:37 |
 |
Peer-Review Started |
|
2026-01-12 01:37 |
 |
First Decision by Editorial Office Director |
|
2026-02-04 10:02 |
 |
Return for Revision |
|
2026-02-04 10:02 |
 |
Revised |
|
2026-02-13 15:20 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-22 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-22 06:58 |
 |
Articles in Press |
|
2026-04-22 06:58 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345